Chemours vs Westlake
Westlake is the larger business, with $11.17bn of revenue in fiscal 2025 against $5.81bn for Chemours (1.9 times as much). Chemours grew faster (0.4% against -8.0%). Chemours kept more of each dollar of sales as profit: a net margin of -6.6% against -13.5%.
| Latest fiscal year | ChemoursCC, 2025 | WestlakeWLK, 2025 |
|---|---|---|
| Revenue | $5.81bn | $11.17bn |
| Revenue growth | 0.4% | -8.0% |
| Net income | −$386m | −$1.51bn |
| Operating margin | — | -14.1% |
| Net margin | -6.6% | -13.5% |
| Return on equity | -94.0% | -15.6% |
| Free cash flow | $51.0m | −$530m |
| Cash | $670m | $2.72bn |
| Total debt | $4.18bn | $5.68bn |
| Debt to equity | — | 64.6% |
| Dividend per share | $0.51 | $2.11 |
| Dividend yield | 2.7% | 3.0% |
| Share buybacks | — | $63.0m |
| Employees | 5,700 | 14,600 |
| Market value | $1.99bn | $8.84bn |
| Price vs our value range | — | Within our value range |
| Moat score | 46 (Moderate) | 43 (Weak) |
| Insider trades, 12 months | 7 buys, 0 sales | 0 buys, 9 sales |